DUBLIN--(BUSINESS WIRE)--The "Bleeding Disorders Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
Global Bleeding Disorders Treatment Market to Reach $22 Billion by 2030
The global market for Bleeding Disorders Treatment estimated at US$14.6 Billion in the year 2022, is projected to reach a revised size of US$22 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030.
Hemophilia A, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$12.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hemophilia B segment is readjusted to a revised 5.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $4 Billion, While China is Forecast to Grow at 8.6% CAGR
The Bleeding Disorders Treatment market in the U.S. is estimated at US$4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.8% and 5.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3 Billion by the year 2030.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Bleeding Disorders Treatment to Witness Steady Growth
- Hemophilia A to Account for Highest Growth
- Total Number of People Worldwide with Bleeding Disorders by Condition: 2017
- Recombinant Coagulation Factor Concentrates to Register Largest Market Share
- Total Recombinant Coagulation Factors Sales of Novo Nordisk
- Bleeding Disorders Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
- Bleeding Disorders Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- A Prelude into Hemophilia Product Sales of Leading Players
- Hemophilia Product Portfolio of Leading Players
- Total Sales of Hemophilia Drugs by Leading Players-2017
- Annual Hemophilia Product Sales of Shire in Billion USD for the years 2015, 2016, and 2017
- Market Share of Novo Nordisk in Haemophilia: 2017
- Total Sales for Novo Nordisk in Haemophilia Segment: 2018
- Select Products in Developmental Stage
- Select Mergers and Acquisitions
-
(Total 46 Featured)
- Bayer AG
- CSL Behring
- Grifols International SA
- Novo Nordisk A/S
- Octapharma AG
- Pfizer, Inc.
3. MARKET TRENDS & DRIVERS
- Increasing Prevalence of Bleeding Disorders to Propel Market Prospects
- Total Number of Patients with Bleeding Disorders for Select Countries: 1999 to 2017
- Total Number Patients with Haemophilia A and Haemophilia B
- Prophylactic Treatment in Hemophilia to Support Market Growth
- Percentage Breakdown of Diagnosis and Treatment Rates in Haemophilia
- Emerging Therapies/ Investments to Spur Market Demand
- New Product Launches/ Approvals to Support Market Growth
- Higher Cost of Drugs to Hinder Bleeding Disorders Treatment
4. GLOBAL MARKET PERSPECTIVE
For more information about this report visit https://www.researchandmarkets.com/r/a1bgdo
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
